Exact Mass: 430.2934
Exact Mass Matches: 430.2934
Found 500 metabolites which its exact mass value is equals to given mass value 430.2934,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ruscogenin
Ruscogenin is a triterpenoid. Ruscogenin is a natural product found in Cordyline rubra, Cordyline banksii, and other organisms with data available. Ruscogenin, an important steroid sapogenin derived from Ophiopogon japonicus, attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Ruscogenin exerts significant anti-inflammatory and anti-thrombotic activities. Ruscogenin has orally bioactivity[1][2]. Ruscogenin, an important steroid sapogenin derived from Ophiopogon japonicus, attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Ruscogenin exerts significant anti-inflammatory and anti-thrombotic activities. Ruscogenin has orally bioactivity[1][2].
Hocogenin
Hecogenin is a triterpenoid. Hecogenin is a natural product found in Yucca gloriosa, Allium rotundum, and other organisms with data available.
Australigenin
Sapogenin from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the US
7-alpha-hydroxy-3-oxo-4-cholestenoate (7-HOCA)
7alpha-Hydroxy-3-oxo-4-cholestenoate, also known as 7-Hoca, is a member of the class of compounds known as monohydroxy bile acids, alcohols, and derivatives. Thes compounds are bile acids, alcohols, or any of their derivatives bearing a hydroxyl group. 7alpha-Hydroxy-3-oxo-4-cholestenoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 7alpha-Hydroxy-3-oxo-4-cholestenoate is involved in metabolic disorders such as 27-hydroxylase deficiency, familial hypercholanemia (FHCA), and Zellweger syndrome. 7alpha-Hydroxy-3-oxo-4-cholestenoate is involved in the primary bile acid biosynthesis pathway. 7alpha-Hydroxy-3-oxo-4-cholestenoate is created from either 3beta,7alpha-dihydroxy-5-cholestenoate or 7alpha,26-dihydroxy-4-cholesten-3-one through the actions of HSD3B7 (EC 1.1.1.181) or CYP27A (EC 1.14.13.15), respectively.
Barogenin
Cryptogenin is a constituent of Balanites aegyptiaca (soapberry tree fruits) Constituent of Balanites aegyptiaca (soapberry tree fruits).
4,4-Diapo-psi,psi-carotene-4-oic acid
2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea. 2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is a constituent of Tussilago farfara (coltsfoot). Constituent of Tussilago farfara (coltsfoot). 2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea.
24-Oxo-1alpha,25-dihydroxyvitamin D3
This compound belongs to the family of Vitamin D and Derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane.
Schidigeragenin C
Genin from Yucca schidigera (Mojave yucca). Schidigeragenin C is found in fruits. Schidigeragenin C is found in fruits. Genin from Yucca schidigera (Mojave yucca
MG(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0/0:0)
MG(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. [HMDB] MG(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.
Piritramide
Piritramide (R-3365, trade names Dipidolor, Piridolan, Pirium and others) is a synthetic opioid analgesic with a potency 0.65 to 0.75 times that of morphine. A common starting dose is 15 mg IV, equivalent to 10 mg of morphine hydrochloride. Piritramide is commonly used for the treatment of postoperative pain. Piritramide was discovered at Janssen Pharmaceutica in 1960 and is currently manufactured and distributed within continental Europe and some other places by Janssen-Cilag. Piritramide is a strong opioid and therefore is regulated much the same as morphine in all known jurisdictions. It was never introduced in the United States and is therefore a Schedule I/Narcotic controlled substance. It is listed under international treaties and other laws such as the German Betabungsmittelgesetz, the Austrian Suchtgiftmittelgesetz, the Opium Laws of various other European countries, Canadian controlled substances act, UK Misuse of Drugs Act of 1971, and equivalents elsewhere. Strangely enough, bezitramide, which is not currently marketed in the United States is a Schedule II/Narcotic controlled substance. Piritramide is also known as pirinitramide. Its closest chemical relatives amongst well-known drugs are diphenoxylate (Lomotil) and bezitramide (Burgodin). Piritramide is available in tablets and ampoules of sterile solution for injection by all routes, and is used in Patient Controlled Analgesia units. In addition to PCA, piritramide is most often used in post-operative situations and emergency departments; some of its properties would seem to lend it well to chronic pain control as well. It is one of the longer-lasting opioids and has a plasma half-life of 3 to 12 hours. Piritramide tends to cause less respiratory depression than morphine and can take a while to have full effect especially if taken by mouth. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
25-Hydroxyvitamin D3-26,23-lactol
This compound belongs to the family of Vitamin D and Derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane.
(25R)-3beta-hydroxycholest-5-en-7-one-26-oate
(25R)-3beta-hydroxycholest-5-en-7-one-26-oate is also known as (3beta,25R)-3-Hydroxy-7-oxocholest-5-en-26-Oate. (25R)-3beta-hydroxycholest-5-en-7-one-26-oate is considered to be practically insoluble (in water) and acidic
N-Eicosapentaenoyl Glutamine
N-eicosapentaenoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Urea, N'-(2,4-difluorophenyl)-N-((4-(2,2-dimethylpropyl)phenyl)methyl)-N-heptyl-
Ruscogenin
MG(PGF1alpha/0:0/0:0)
MG(PGF1alpha/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/PGF1alpha/0:0)
MG(0:0/PGF1alpha/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
DG(2:0/18:1(12Z)-2OH(9,10)/0:0)
DG(2:0/18:1(12Z)-2OH(9,10)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/18:1(12Z)-2OH(9,10)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:1(12Z)-2OH(9,10)/2:0/0:0)
DG(18:1(12Z)-2OH(9,10)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-2OH(9,10)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/18:1(12Z)-2OH(9,10))
DG(2:0/0:0/18:1(12Z)-2OH(9,10)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:1(12Z)-2OH(9,10)/0:0/2:0)
DG(18:1(12Z)-2OH(9,10)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Nuatigenin
Nuatigenin belongs to furospirostanes and derivatives class of compounds. Those are heterocyclic steroids containing a furospirostane moiety, which a skeleton characterized by the presence of a 1,6-dioxaspiro[4.4]nonane ring system and an androstane moiety. Nuatigenin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Nuatigenin can be found in oat, which makes nuatigenin a potential biomarker for the consumption of this food product.
Kuguacin E
Kuguacin e is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Kuguacin e can be found in bitter gourd, which makes kuguacin e a potential biomarker for the consumption of this food product.
Yuccagenin
Yuccagenin is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. Yuccagenin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Yuccagenin can be found in fenugreek, which makes yuccagenin a potential biomarker for the consumption of this food product.
Laurebiphenyl
A sesquiterpenoid that is a dimer of a cyclolaurane type sesquiterpene. Isolated from the marine red algae Laurencia nidifica and Laurencia tristicha, it exhibits antineoplastic activity.
Lupulone C
Lupulone C is a natural product found in Humulus lupulus with data available.
Cryptogenin
4-(3-ACO-10,13-DI-ME-1H-CYCLOPENTA(A)PHENANTHREN-17-YL)-PENTANOIC ACID ME ESTER
3beta,6alpha,20xi-Trihydroxy-5alpha-cholesta-9(11),24-dien-23-on|3beta,6alpha,20xi-trihydroxy-5alpha-cholesta-9(11),24-dien-23-one
gutierrezianolic acid (2-methylbutyrate) methyl ester|gutierrezianolic acid <2-methylbutyrate> methyl ester
15alpha-Angeloyloxy-9beta-hydroxy-kaur-16-en-saeuremethylester|15alpha-angeloyloxy-stenolobin|ent-15beta-angeloxy-9alpha-hydroxykaur-16-en-19-oate|methyl 15alpha-angeloyloxy-9beta-hydroxy-ent-kaur-16-en-19-oate
(5alpha,12beta,25R)-12-Hydroxyspirostan-3-one|Hispidogenin
12alpha-hydroxy-24-methyl-24,25-dioxoscalar-16-en-22-oic acid
(20S,22E)-cholesta-1,22-diene-16beta,18,20-triol-3-one
9beta-hydroxy-15alpha-senecioyloxy-ent-kaurensaeure-methyl-ester
(5alpha,12alpha,25S)-12-Hydroxyspirostan-3-one|Torvogenin
24xi-hydroperoxy-6beta-hydroxycholesta-4,25-dien-3-one
12alpha,24alpha-dihydroxy-20,24-dimethyl-25-norscalar-17-ene-18,24-carbolactone|phyllolactone E
gutierrezianolic acid (isobutyrate) methyl ester|gutierrezianolic acid methyl ester
(7R*,8R*)-6-hydroxy-2,8-dimethyl-2-((3E)-4,8,12-trimethyl-7,8-dihydroxytrideca-3,11-dien-1-yl)chroman|(7R*,8R*)-6-hydroxy-2,8-dimethyl-2-<(3E)-4,8,12-trimethyl-7,8-dihydroxytrideca-3,11-dien-1-yl>chroman
3beta-3,29-Dihydroxy-15-oxo-24,25,26-trinorlanosta-8,16-dien-23-oic acid
3alpha-hydroxy-21alpha-methoxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone
3beta,9alpha-dihydroxycholest-7-en-6,23-dione|grandol D
16,22-epoxy-20beta,23S-dihydroxycholest-1-ene-3-one
12alpha-(2-methylbutyryloxy)-hardwickiic acid methyl ester|12alpha-<2-methylbutyryloxy>-hardwickiic acid methyl ester
23alpha-hydroxy-3-oxo-25,26,27-trinordammar-24,20alpha-olide
(25R)-Spirost-4-en-2alpha,3beta-diol|(25R)-spirost-4-ene-2alpha,3beta-diol|yuccagenin
(3S,5Z,7E)-3,23,25-Trihydroxy-9,10-secocholesta-5,7,10(19)-trien-24-one
methyl-15beta-tiglinoyloxy-16,17-epoxy-ent-kaurane
methyl-3alpha-angeloyloxy-9beta-hydroxy-ent-kaurenoate
ent-7alpha-senecioxy-15alpha-hydroxy-atis-16-en-19-oic acid
25-hydroperoxy-6beta-hydroxycholesta-4,23-dien-3-one
cholesta-1,4-dien-12beta,16beta,20alpha-triol-3-one
(3beta)-25,26,27-trinorcucurbita-5,24-diene-7,23-dione-3,29-diol|balsaminol D
gammar-Lactone-(3S,5E,7E,10S)-3,23,25-Trihydroxy-9,10-secocholesta-5,7-dien-26-oic acid
1,2-Dihydro-(16beta,22E)-16,18,20-Trihydroxycholesta-1,4,22-trien-3-one
3beta-hydroxy-5alpha,6alpha-epoxy-9-oxo-9,11-seco-5alpha-cholest-7-en-11-al
(2E,6E)-2-(10(S),11(S)-dihydroxygeranylgeranyl)-6-methylquinol|2-(10,11-Dihydroxygeranylgeranyl)-6-methyl-1,4-benzenediol
2alpha,11-dihydroxy-9,11-seco-cholest-4,7-dien-6,9-dione
(1S,23R,5Z,7E)-1,3,25-Trihydroxy-9,10-secocholesta-5,7,10(19)-trien-23-one
1,2-Dihydro,27-nor-(16beta,22E)-16,18,20-Trihydroxy-24-methylcholesta-1,4,22-trien-3-one
rel-(1R,5R)-2-(1-farnesyl-5-acetoxy-2-oxocyclohex-3-en-1-yl)-acetic acid methyl ester
(25RS)-Ruscogenin
Ruscogenin suppresses HCC metastasis by reducing the expression of MMP-2, MMP-9, uPA, VEGF and HIF-1α via regulating the PI3K/Akt/mTOR signaling pathway[1]. And Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by su Ruscogenin suppresses HCC metastasis by reducing the expression of MMP-2, MMP-9, uPA, VEGF and HIF-1α via regulating the PI3K/Akt/mTOR signaling pathway[1]. And Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by su Ruscogenin suppresses HCC metastasis by reducing the expression of MMP-2, MMP-9, uPA, VEGF and HIF-1α via regulating the PI3K/Akt/mTOR signaling pathway[1]. And Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by su
Pennogenin
Pennogenin is an oxaspiro compound that is spirost-5-en substituted by hydroxy groups at positions 3 and 17 (3beta,25R stereoisomer). It has a role as a metabolite. It is a 17alpha-hydroxy steroid, an oxaspiro compound, an organic heterohexacyclic compound, a sapogenin and a 3beta-hydroxy-Delta(5)-steroid. It derives from a hydride of a spirostan. Pennogenin is a natural product found in Paris polyphylla var. chinensis, Polygonatum stenophyllum, and other organisms with data available. An oxaspiro compound that is spirost-5-en substituted by hydroxy groups at positions 3 and 17 (3beta,25R stereoisomer).
C27H42O4_(3beta,5alpha,8xi,9xi,14xi,25S)-3-Hydroxyspirostan-12-one
Gly Lys Lys Val
Gly Lys Val Lys
Gly Val Lys Lys
Ile Ile Ser Val
Ile Ile Val Ser
Ile Leu Ser Val
Ile Leu Val Ser
Ile Ser Ile Val
Ile Ser Leu Val
Ile Ser Val Ile
Ile Ser Val Leu
Ile Thr Val Val
Ile Val Ile Ser
Ile Val Leu Ser
Ile Val Ser Ile
Ile Val Ser Leu
Ile Val Thr Val
Ile Val Val Thr
Lys Gly Lys Val
Lys Gly Val Lys
Lys Lys Gly Val
Lys Lys Val Gly
Lys Val Gly Lys
Lys Val Lys Gly
Leu Ile Ser Val
Leu Ile Val Ser
Leu Leu Ser Val
Leu Leu Val Ser
Leu Ser Ile Val
Leu Ser Leu Val
Leu Ser Val Ile
Leu Ser Val Leu
Leu Thr Val Val
Leu Val Ile Ser
Leu Val Leu Ser
Leu Val Ser Ile
Leu Val Ser Leu
Leu Val Thr Val
Leu Val Val Thr
Ser Ile Ile Val
Ser Ile Leu Val
Ser Ile Val Ile
Ser Ile Val Leu
Ser Leu Ile Val
Ser Leu Leu Val
Ser Leu Val Ile
Ser Leu Val Leu
Ser Val Ile Ile
Ser Val Ile Leu
Ser Val Leu Ile
Ser Val Leu Leu
Thr Ile Val Val
Thr Leu Val Val
Thr Val Ile Val
Thr Val Leu Val
Thr Val Val Ile
Thr Val Val Leu
Val Gly Lys Lys
Val Ile Ile Ser
Val Ile Leu Ser
Val Ile Ser Ile
Val Ile Ser Leu
Val Ile Thr Val
Val Ile Val Thr
Val Lys Gly Lys
Val Lys Lys Gly
Val Leu Ile Ser
Val Leu Leu Ser
Val Leu Ser Ile
Val Leu Ser Leu
Val Leu Thr Val
Val Leu Val Thr
Val Ser Ile Ile
Val Ser Ile Leu
Val Ser Leu Ile
Val Ser Leu Leu
Val Thr Ile Val
Val Thr Leu Val
Val Thr Val Ile
Val Thr Val Leu
Val Val Ile Thr
Val Val Leu Thr
Val Val Thr Ile
Val Val Thr Leu
isopropyl ester
3beta-Hydroxy-5alpha,6alpha-epoxy-9-oxo-9,10-seco-5-cholest-7-en-11-al
(5Z,7E)-(1S,3R,24R,25R)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
(5Z,7E)-(1S,3R,24R,25S)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
(5Z,7E)-(1S,3R,24S,25R)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
(5Z,7E)-(1S,3R,24S,25S)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
1α,25-dihydroxy-24-oxovitamin D3 / 1α,25-dihydroxy-24-oxocholecalciferol
(23S)-23,25-dihydroxy-24-oxovitamin D3 / (23S)-23,25-dihydroxy-24-oxocholecalciferol
(23S,25R)-25-hydroxyvitamin D3 26,23-lactol / (23S,25R)-25-hydroxycholecalciferol 26,23-lactol
(5Z,7E,22E)-(1S,3R,24R)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24,25-tetrol
(5Z,7E,22E)-(1S,3R,24S)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24,25-tetrol
(5Z,7E,22E)-(1S,3R,25R)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25,26-tetrol
(5Z,7E,22E)-(1S,3R,25S)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25,26-tetrol
1,25-Dihydroxy-23-oxo-vitamin D3
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
15-keto Latanoprost
Australigenin
Schidigeragenin C
2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
Piritramide
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
(24R,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
(24R,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
(24S,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
(24S,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3
1alpha,25-dihydroxy-18-oxovitamin D3 / 1alpha,25-dihydroxy-18-oxocholecalciferol
1alpha,25-dihydroxy-24-oxovitamin D3
(23S,25R)-25-hydroxyvitamin D3 26,23-lactol
D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
[1R-(1a,2b,3a,5a)]-5-Hydroxy-2-[(1-methoxy-1-methylethoxy)methyl]-3-[(tetrahydro-2H-pyran-2-yl)oxy]cyclopentaneheptanoic acidmethylester
TRIETHYL 2,2,2-(1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE
Calcipotriene hydrate
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D003879 - Dermatologic Agents
2-ethylhexyl prop-2-enoate,2-methylpropyl 2-methylprop-2-enoate,styrene
(EZ)-3-hydroxy-6-ethylidene-7-keto-5-cholan-24-oic acid methyl ester
Resocortol butyrate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
12-Epi-Deoxoscalarin
A scalarane sesterterpenoid that is the deoxo derivative of 12-epi-scalarin. It has been isolated from the sponge,Hyattella species.
(1S)-1,25-dihydroxy-24-oxocalciol
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
(25R)-3beta-Hydroxycholest-5-en-7-one-26-Oic acid
A cholestanoid resulting from the oxidation of (25R)-3beta,26-dihydroxycholest-5-en-7-one to the corresponding carboxylic acid.
(24R,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24R,25R)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
(24R,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24R,25S)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
(24S,25R)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24S,25R)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
(24S,25S)-25,26-epoxy-1alpha,24-dihydroxyvitamin D3/(24S,25S)-25,26-epoxy-1alpha,24-dihydroxycholecalciferol
1alpha,25-dihydroxy-18-oxovitamin D3/1alpha,25-dihydroxy-18-oxocholecalciferol
23(S),25-dihydroxy-24-oxovitamin D3
A hydroxycalciol that is 25-hydroxyvitamin D3 carrying an additional hydroxy group at position 23 (with 23S-configuration) and an oxo group at position 24. An intermediate in the degradation pathway of 25-OH-vitamin D3.
(23S,25R)-25-hydroxyvitamin D3 26,23-lactol/(23S,25R)-25-hydroxycholecalciferol 26,23-lactol
(22E)-(24R)-1alpha,24,25-trihydroxy-22,23-didehydrovitamin D3/(22E)-(24R)-1alpha,24,25-trihydroxy-22,23-didehydrocholecalciferol
(22E)-(24S)-1alpha,24,25-trihydroxy-22,23-didehydrovitamin D3/(22E)-(24S)-1alpha,24,25-trihydroxy-22,23-didehydrocholecalciferol
(22E)-(25R)-1alpha,25,26-trihydroxy-22,23-didehydrovitamin D3/(22E)-(25R)-1alpha,25,26-trihydroxy-22,23-didehydrocholecalciferol
(22E)-(25S)-1alpha,25,26-trihydroxy-22,23-didehydrovitamin D3/(22E)-(25S)-1alpha,25,26-trihydroxy-22,23-didehydrocholecalciferol
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-24-hydroxy-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenal
(1R,4S,5S,8R,9R,12R,13S,16S)-16-hydroxy-5,9,17,17-tetramethyl-8-(4-oxopentan-2-yl)-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadecan-3-one
(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoic acid
(1R,2S,4S,7S,8R,9S,12S,13S,16S,18S)-16-Hydroxy-5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2-oxane]-10-one
asnovolin J
A meroterpenoid with formula C26H38O5 isolated from the fungus Aspergillus novofumigatus. It is an intermediate produced in the biosynthetic pathway leading to the synthesis of novofumigatonin.
methyl (1R,2S,5S,7R,10S,11S,13R,15R)-7-hydroxy-2,6,6,10,13,15-hexamethyl-17-methylidene-14,16-dioxotetracyclo[11.3.1.02,11.05,10]heptadecane-1-carboxylate
17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoheptadecanoic acid
(16R)-16-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxoheptadecanoic acid
Andrastin E
A 17-oxo steroid that is andrastin D in which the keto group at position 3 has undergone formal reduction to give the corresponding 3alpha-hydroxy compound.
Andrastin F
A 17-oxo steroid that is andrastin D in which the keto group at position 3 has undergone formal reduction to give the corresponding 3beta-hydroxy compound.
(6R)-6-[(7R,10R,13R,17R)-7-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid
methyl (3R)-3-[(2E,6E)-9-[(2R)-3,3-dimethyloxiran-2-yl]-3,7-dimethylnona-2,6-dienyl]-6-hydroxy-2,3,5-trimethyl-4-oxocyclohexa-1,5-diene-1-carboxylate
[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] acetate
(2alpha,8xi,9xi,14xi,16xi,17xi)-Spirost-5-en-2,3-diol
7alpha-hydroxy-3-oxo-4-cholestenoic acid
A cholestanoid that is cholest-4-en-26-oic acid substituted by an alpha-hydroxy group at position 7 and an oxo group at position 3. It is an intermediate metabolite in the bile acid synthesis.
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenoic acid
12beta,16beta,20R-trihydroxy-cholest-1,4-dien-3-one
3beta,5alpha,9alpha-Trihydroxycholesta-7,14-dien-6-one
5alpha,9alpha-Epidioxy-8,14alpha-epoxy-cholest-6-en-3beta-ol
4,4-diapolycopen-4-oic acid
An apo carotenoid triterpenoid that is 4,4-diapolycopene in which one of the terminal methyl groups has been replaced by a carboxy group.
